Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 118 (RN7SKP118) is a pseudogene related to the functional small nuclear noncoding RNA 7SK (RN7SK), which itself is known to regulate RNA polymerase II transcriptional elongation as part of the 7SK small nuclear ribonucleoprotein (snRNP) complex[1][2]. Functional 7SK RNA acts as a regulator of gene expression, particularly through modulation of P-TEFb activity, chromatin accessibility, and splicing, especially in neuronal and skin tissues[1][2]. However, the RN7SKP118 entity itself is a \"pseudogene\"—a non-functional genomic segment resulting from duplication or retrotransposition and does not code for a functional RNA or protein product, nor is it recognized as a receptor, enzyme, transporter, or therapeutically relevant molecular target[1][2]. No data supports any specific biological or disease-related function for RN7SKP118.
Not applicable; no approved or experimental drugs known to interact with pseudogenes of RN7SK.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 118 (RN7SKP118).